CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2020; 4(01): 21-26
DOI: 10.4103/AJIR.AJIR_9_19
Original Article

Continuous Aspiration Mechanical Thrombectomy for Treatment of Thrombosed Hemodialysis ReliableOutflow Grafts

Osman Ahmed
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
,
Mohamad Omar Hadied
Department of Radiology, Wayne State University School of Medicine, Detroit, MI, USA
,
Sreekumar Madassery
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
,
Merve Ozen
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
,
Patrick Tran
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
,
Adolfo E. Lizardo
Department of Radiology, South Medical Clinic and Hospital, National Institute of Cancer, Mexico City, Mexico
,
Jordan C. Tasse
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
,
Ulku Cenk Turba
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
,
Bulent Arslan
Department of Radiology, Section of Interventional Radiology, Rush University Medical Center, Chicago, IL
› Author Affiliations
Financial support and sponsorship Nil.

Aims: To determine the safety and feasibility of continuous aspiration mechanical thrombectomy (CAT) for restoring patency to thrombosed hemodialysis reliable outflow (HeRO) arteriovenous grafts. Subjects and Methods: Between December 2016 and August 2017, eleven consecutive patients (average age 63, range 39–80 years) with thrombosed HeRO grafts underwent percutaneous thrombectomy procedures (n = 21) using the Penumbra Indigo® CAT 8 or CAT D (Alameda, CA, USA) thrombectomy catheter as the primary device to clear the venous outflow tract before removing the arterial plug with a compliant balloon. A total of 21 hemodialysis declot procedures using CAT were documented and analyzed. Average procedure length and fluoroscopy time, length of thrombus cleared, blood loss, complications, and time between thrombectomy procedures were recorded and compared to the same patient's previous three thrombectomy procedures. Results: All procedures were technically successful (100%) at restoring graft patency; however, reocclusion within 5 days occurred in four (19.0%) cases. Three (14.3%) interventions required additional balloon maceration or sweep to clear the venous outflow following thrombectomy. Average thrombus length treated by suction thrombectomy measured 23.15 cm (range 2.2–65 cm). Average blood loss was 162.6 mL (range 50–250 mL). No procedure-related complications were recorded. The average procedure length and fluoroscopy time using suction thrombectomy was 74.7 and 14.2 min, respectively, compared with 82.0 and 14.0 min, respectively, in the previous thrombectomy procedures using standard methods (P > 0.05). Seventeen (81%) HeRO grafts treated by CAT presented with rethrombosis at a mean of 42.47 days (range 1–208 days, median 22 days, standard deviation [SD] 28.2 days) since CAT procedure compared to patients treated by conventional methods who presented for rethrombosis at a mean of 55.33 days (range 1–321 days, median 34 days, SD 43.1 days) since standard thrombectomy – no statically significant difference (P > 0.05). Conclusion: CAT is a safe and feasible method for removing thrombus and restoring patency to thrombosed HeRO grafts. Further studies are required to elucidate the advantages of CAT over standard thrombectomy techniques.



Publication History

Received: 27 May 2019
Received: 30 May 2019

Accepted: 08 June 2019

Article published online:
16 March 2021

© 2019. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Young S, Pritzker M, Rosenberg M. Vacuum-assisted thrombectomy of massive pulmonary embolism. J Vasc Interv Radiol 2016;27:1094-6.
  • 2 Baumann F, Sharpe E 3rd, Peña C, Samuels S, Benenati JF. Technical results of vacuum-assisted thrombectomy for arterial clot removal in patients with acute limb ischemia. J Vasc Interv Radiol 2016;27:330-5.
  • 3 Gebhard TA, Bryant JA, Adam Grezaffi J, Pabon-Ramos WM, Gage SM, Miller MJ, et al. Percutaneous interventions on the hemodialysis reliable outflow vascular access device. J Vasc Interv Radiol 2013;24:543-9.
  • 4 Vieira M, Ferreira T, Fortes A, Marins P, Ministro A, Ferreira H, et al. Hemodialysis Reliable Outflow (HeRO) Graft device: A lifesaving solution in multiple vascular access failure in haemodialysis patients. Port J Nephrol Hypert 2016;30:217-22.
  • 5 Yigla M, Abassi Z, Reisner SA, Nakhoul F. Pulmonary hypertension in hemodialysis patients: An unrecognized threat. Semin Dial 2006;19:353-7.
  • 6 Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration 2007;74:503-10.
  • 7 Centers for Medicare and Medicaid Services, Kinney R 2005 annual report: ESRD clinical performance measures project. Am J Kidney Dis 2006;48:S1-106.
  • 8 Smits HF, Smits JH, Wüst AF, Buskens E, Blankestijn PJ. Percutaneous thrombolysis of thrombosed haemodialysis access grafts: Comparison of three mechanical devices. Nephrol Dial Transplant 2002;17:467-73.
  • 9 Petronis JD, Regan F, Briefel G, Simpson PM, Hess JM, Contoreggi CS, et al. Ventilation-perfusion scintigraphic evaluation of pulmonary clot burden after percutaneous thrombolysis of clotted hemodialysis access grafts. Am J Kidney Dis 1999;34:207-11.
  • 10 Rigatelli G, Martire G, Gentile M, Michielan F, Amistà P. Combined use of export catheter and penumbra vacuum thromboaspiration in a challenging case of acute common carotid artery occlusion. Cardiovasc Revasc Med 2016;17:468-9.
  • 11 Smith SJ, Behrens G, Sewall LE, Sichlau MJ. Vacuum-assisted thrombectomy device (AngioVac) in the management of symptomatic iliocaval thrombosis. J Vasc Interv Radiol 2014;25:425-30.
  • 12 Al Badri A, Kliger C, Weiss D, Pirelli L, Wilson S, DeLaney ER, et al. Right atrial vacuum-assisted thrombectomy: Single-center experience. J Invasive Cardiol 2016;28:196-201.
  • 13 Monastiriotis S, Gonzales C, Kokkosis A, Labropoulos N, Bilfinger T, Tassiopoulos AK, et al. The use of angioVac for symptomatic aortic thrombus complicated by mesenteric ischemia. Ann Vasc Surg 2016;32:129.e1-6.
  • 14 George B, Voelkel A, Kotter J, Leventhal A, Gurley J. A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno-venous bypass: A single center experience. Catheter Cardiovasc Interv 2017;90:1009-15.
  • 15 Dariushnia SR, Walker TG, Silberzweig JE, Annamalai G, Krishnamurthy V, Mitchell JW, et al. Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit. J Vasc Interv Radiol 2016;27:1518-30.
  • 16 Ahmed O, Patel K, Rabei R, Patel MV, Ginsburg M, Clayton B, et al. Hemodialysis access maintenance in the medicare population: An analysis over a decade of trends by provider specialty and site of service. J Vasc Interv Radiol 2018;29:159-69.
  • 17 Wallace JR, Chaer RA, Dillavou ED. Report on the hemodialysis reliable outflow (HeRO) experience in dialysis patients with central venous occlusions. J Vasc Surg 2013;58:742-7.
  • 18 Katzman HE, McLafferty RB, Ross JR, Glickman MH, Peden EK, Lawson JH, et al. Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. J Vasc Surg 2009;50:600-7, 607.e1.
  • 19 Ladenheim ED, Lulic D, Lum C, Agrawal S. Primary and secondary patencies of transposed femoral vein fistulas are significantly greater than with the heRO graft. J Vasc Access 2017;18:232-7.
  • 20 Al Shakarchi J, Houston JG, Jones RG, Inston N. A review on the hemodialysis reliable outflow (HeRO) graft for haemodialysis vascular access. Eur J Vasc Endovasc Surg 2015;50:108-13.
  • 21 Gibbens DT, Triolo J, Yu T, Depalma J, Iglasias J, Castner D, et al. Contemporary treatment of thrombosed hemodialysis grafts. Tech Vasc Interv Radiol 2001;4:122-6.
  • 22 Coan KE, O'Donnell ME, Fankhauser GT, Bodnar Z, Chandrasekaran K, Stone WM, et al. Bilateral pulmonary emboli secondary to indwelling hemodialysis reliable outflow catheter. Vasc Endovascular Surg 2013;47:317-9.
  • 23 Calderon K, Jhaveri KD, Mossey R. Pulmonary embolism following thrombolysis of dialysis access: Is anticoagulation really necessary? Semin Dial 2010;23:522-5.
  • 24 Smits HF, Van Rijk PP, Van Isselt JW, Mali WP, Koomans HA, Blankestijn PJ, et al. Pulmonary embolism after thrombolysis of hemodialysis grafts. J Am Soc Nephrol 1997;8:1458-61.
  • 25 Sadjadi SA, Sharif-Hassanabadi M. Fatal pulmonary embolism after hemodialysis vascular access declotting. Am J Case Rep 2014;15:172-5.
  • 26 Gilmore B, Benrashid E, Youngwirth LM, Lawson JH. Paradoxical embolus following percutaneous thrombectomy of hemodialysis reliable outflow graft. J Vasc Access 2015;16:533-6.
  • 27 Hsieh MY, Lai CL, Wu YW, Lin L, Ho MC, Wu CC, et al. Impact on pulmonary arterial pressures after repeated endovascular thrombectomy of dialysis grafts: A prospective follow-up study. J Vasc Interv Radiol 2014;25:1883-9.
  • 28 Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 2009;75:969-75.
  • 29 Harp RJ, Stavropoulos SW, Wasserstein AG, Clark TW. Pulmonary hypertension among end-stage renal failure patients following hemodialysis access thrombectomy. Cardiovasc Intervent Radiol 2005;28:17-22.